Ventas (NYSE:VTR) Releases FY 2026 Earnings Guidance

Ventas (NYSE:VTR) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 3.850-3.900 for the period, compared to the consensus earnings per share estimate of 3.880. The company issued revenue guidance of -.

Ventas Price Performance

Shares of VTR traded down $0.28 during trading hours on Thursday, hitting $92.25. The stock had a trading volume of 983,914 shares, compared to its average volume of 3,675,292. The stock has a market capitalization of $47.32 billion, a price-to-earnings ratio of 170.60, a P/E/G ratio of 2.10 and a beta of 0.69. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. The company’s fifty day moving average is $89.19 and its two-hundred day moving average is $85.96. Ventas has a 52 week low of $66.38 and a 52 week high of $101.60.

Ventas Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th were paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Tuesday, June 30th. Ventas’s dividend payout ratio is currently 385.19%.

Analyst Upgrades and Downgrades

VTR has been the topic of a number of recent research reports. KeyCorp increased their price objective on Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. BMO Capital Markets reiterated an “outperform” rating and issued a $100.00 price target on shares of Ventas in a report on Monday, May 4th. Barclays started coverage on Ventas in a research report on Tuesday, July 7th. They issued an “equal weight” rating and a $99.00 price objective for the company. JPMorgan Chase & Co. boosted their price objective on Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Finally, Scotiabank cut their target price on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. Fifteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, Ventas presently has a consensus rating of “Moderate Buy” and an average target price of $97.56.

Insider Buying and Selling

In other Ventas news, Director Michael J. Embler bought 2,500 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the purchase, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the sale, the director directly owned 28,349 shares in the company, valued at approximately $2,557,079.80. This represents a 3.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.53% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. NewEdge Advisors LLC raised its holdings in shares of Ventas by 856.1% in the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock valued at $545,000 after purchasing an additional 7,097 shares during the last quarter. Empowered Funds LLC grew its holdings in shares of Ventas by 6.8% in the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after acquiring an additional 536 shares in the last quarter. Woodline Partners LP boosted its position in Ventas by 46.8% during the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after purchasing an additional 11,739 shares during the last quarter. Focus Partners Wealth boosted its position in Ventas by 130.4% during the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after purchasing an additional 12,233 shares during the last quarter. Finally, Gamco Investors INC. ET AL bought a new position in Ventas in the second quarter valued at approximately $805,000. Institutional investors own 94.18% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.